Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

Over 60% of Korean military personnel had skin diseases, commonly acne and athlete's foot, linked to service length and stress.

G allele of AR Stul polymorphism linked to higher hair loss risk, especially in white people.

Men with Kennedy disease have less chance of hair loss.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The review suggests that understanding and treating the psychological aspect of skin disorders is important and calls for more collaboration in this field.

Alopecia Areata causes emotional stress and stigma, but those with severe hair loss may adapt better.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

The hair follicle pathway significantly affects how easily water-loving chemicals pass through the skin.

Stem cell therapy may help treat tough hair loss cases.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

Many skin patients have mental health issues, but few dermatologists are well-versed in treating these conditions.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

A male with aromatase deficiency improved bone health with estradiol treatment.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Vertex pattern hair loss linked to higher prostate cancer risk.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.